Across Illinois, hospitals and clinics are facing a growing need for highly skilled nurses who can manage complex patient cases. Many registered nurses in the state say they feel limited by their ...
Health technology company WellSky is partnering with Suki to integrate its ambient AI scribe into the company's specialty ...
Art and science building intelligence at the point of conversation enhances clinical decision-making and patient care across health systems.
zSpace Expands Health Science Portfolio with New Immersive Applications for Anatomy and ECG Training
SAN JOSE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC), a global leader in immersive augmented (AR) ...
A survey of reasoning behaviour in medical large language models uncovers emerging trends, highlights open challenges, and introduces theoretical frameworks that enhance reasoning behaviour ...
5don MSN
Researchers pose five guiding questions to improve use of AI in physicians' clinical decision-making
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has ...
News-Medical.Net on MSN
Researchers propose five key questions for effective adoption of AI in clinical practice
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its ...
News-Medical.Net on MSN
AI in Healthcare: How generative tools are transforming clinical practice
Discover how generative AI is reshaping clinical care with real-world examples, challenges, and expert advice for AI adoption ...
Hospitals tap nurses to create bedside technology, improving design and usability by involving frontline staff ...
Objectives To identify common recommendations for high-quality care for the most common musculoskeletal (MSK) pain sites encountered by clinicians in emergency and primary care (spinal (lumbar, ...
An experimental therapy for Parkinson's disease being developed by Roche and Prothena has missed the mark in a phase 2b trial, leaving them sifting through the data for signals of efficacy. The PADOVA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results